1. Home
  2. ACCL vs CVM Comparison

ACCL vs CVM Comparison

Compare ACCL & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Group Holdings Limited Ordinary Shares

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$2.54

Market Cap

36.3M

ML Signal

N/A

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

BUY

Current Price

$1.57

Market Cap

30.6M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
ACCL
CVM
Founded
2009
1983
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
30.6M
IPO Year
2024
1996

Fundamental Metrics

Financial Performance
Metric
ACCL
CVM
Price
$2.54
$1.57
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $12.50
AVG Volume (30 Days)
5.6K
★ 273.5K
Earning Date
11-16-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.13
★ N/A
Revenue Growth
N/A
★ 65.45
52 Week Low
$1.23
$0.89
52 Week High
$5.00
$9.28

Technical Indicators

Market Signals
Indicator
ACCL
CVM
Relative Strength Index (RSI) 45.52 40.69
Support Level $2.41 $1.01
Resistance Level $3.07 $1.79
Average True Range (ATR) 0.21 0.20
MACD 0.00 -0.06
Stochastic Oscillator 54.43 2.28

Price Performance

Historical Comparison
ACCL
CVM

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: